IAEA Activities on


Journal

Current radiopharmaceuticals
ISSN: 1874-4729
Titre abrégé: Curr Radiopharm
Pays: United Arab Emirates
ID NLM: 101468718

Informations de publication

Date de publication:
2021
Historique:
received: 04 05 2020
revised: 09 07 2020
accepted: 20 07 2020
pubmed: 30 9 2020
medline: 17 12 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

Despite interesting properties, the use of

Identifiants

pubmed: 32988359
pii: CRP-EPUB-110294
doi: 10.2174/1874471013999200928162322
doi:

Substances chimiques

Copper Radioisotopes 0
Copper-67 0
Radioisotopes 0
Radiopharmaceuticals 0
Rhenium-186 0
Scandium-47 0
Rhenium 7440-15-5
Scandium YUJ4U1EW7R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-314

Subventions

Organisme : DOE Isotope Program
ID : DESC0020197
Organisme : The Polish Ministry of Science and Higher Education research funds (2017-2018; co-financing international projects)
ID : 3639/FAO/IAEA/16/2017/0, 3574/IAEA/2016/0
Organisme : CERAD project, financed under Smart Growth Operational Programme 2014-2020, Priority IV
ID : MEASURE 4.2.POIR.04.02.00-14-A001/16
Organisme : Nuclear R&D Program and NRF
ID : 2017M2A2A6A05016600

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Amir R Jalilian (AR)

Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna International Centre, PO Box 100, 1400, Vienna, Austria.

Mohamed A Gizawy (MA)

Radioisotopes Production Facility (RPF), Second Research Reactor (ETRR-2) and Labeled Compounds Department, Hot Labs Center, Egyptian Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt.

Cyrille Alliot (C)

CRCINA, 8 quai Moncousu, 44007 Nantes cedex 1, France & GIP Arronax, 1 rue Aronnax, 44817 Saint-Herblain cedex, France & GIP ARRONAX, rue Aronnax, CS 10112 - 44817 SAINT-HERBLAIN Cedex, France.

Sandor Takacs (S)

Institute for Nuclear Research, Bem ter 18/c, 4026Debrecen, Hungary.

Sudipta Chakarborty (S)

Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai -4000, 085, India.

Mohammad R A Rovais (MRA)

Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), P.O. Box 14395-836, Tehran, Iran.

Gaia Pupillo (G)

Istituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Legnaro (INFN-LNL), Viale dell'Università 2, 35020 Legnaro (PD), Italy.

Kotaro Nagatsu (K)

Dept. of Radiopharmaceuticals Development, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage, 263-8555Chiba, Japan.

Jeong H Park (JH)

Korea Atomic Energy Research Institute, Jeongeup, Jeonbuk 56212, Korea.

Mayeen Uddin Khandaker (MU)

Department of Physics, University of Malaya, 50603 Kuala Lumpur, Malaysia & Center for Biomedical Physics, Sunway University, 47500 Bandar Sunway, Selangor, Malaysia.

Renata Mikolajczak (R)

Radioisotope Centre POLATOM, National Centre for Nuclear Research, Andrzej Soltan 7, 05-400, Otwock, Poland.

Aleksander Bilewicz (A)

Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195Warsaw, Poland.

Subhani Okarvi (S)

Cyclotron and Radiopharmaceuticals Department. King Faisal Specialist Hospital and Research Centre, Takhasussi Road, P.O. Box 3354, 11211Riyadh, Saudi Arabia.

Katherine Gagnon (K)

Cyclotrons and TRACERcenter, GEMS PET Systems AB, GE Healthcare, Uppsala, Sweden.

Abdul H Al Rayyes (AH)

Department of Radioisotope, Atomic Energy Commission of Syria (AECS), P.O. Box 6091, Damascus, Syrian Arab Republic.

Suzanne E Lapi (SE)

Cyclotron Facility, Division of Advanced Medical Imaging Research, Department of Radiology and Chemistry, University of Alabama at Birmingham, Wallace Tumor Institute 310F, 1824 6th Ave. South, Birmingham, AL35233-3300, United States.

Valeriia Starovoitova (V)

Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna International Centre, PO Box 100, 1400, Vienna, Austria.

Aruna Korde (A)

Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna International Centre, PO Box 100, 1400, Vienna, Austria.

Joao A Osso (JA)

Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna International Centre, PO Box 100, 1400, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH